Danny Hind BA (Cambridge), MA, PhD (Sheffield)
Research Fellow and Assistant Director, Clinical Trials Research Unit
Clinical Trials Research Unit, ScHARR
The University of Sheffield
Regent Court
30 Regent Street
Sheffield
S1 4DA
Tel: +44 (0)114 222 0707
Fax: +44 (0)114 272 4095
email : d.hind@sheffield.ac.uk
Biography
I have worked with the CTRU since 2007. My principle role is to assist investigators in the design and costing of research studies. I also manage two controlled trials. The CoSMoS study evaluates the use of cognitive behavioural therapy software for the treatment of depression in people with multiple sclerosis. The Sheffield Physical Activity Booster Study, evaluates the effect of motivational interviewing in sustaining activity levels.
Prior to joining CTRU, I worked with ScHARR Technology Assessment Group from June 2000, where I undertook health technology assessments for the National Institute for Health and Clinical Excellence (NICE) and the National Co-ordinating Centre for Health Technology Assessment (NCCHTA). I have undertaken reviews for the Cochrane Cystic Fibrosis & Genetic Disorders Review Group and the Cochrane Breast Cancer Group. From September 2009, I was seconded, for two days a week, to Sheffield's NICE Centre for Public Health Excellence research unit.
Research interests
- Systematic reviews
- Controlled clinical trials
- Qualitative research
- Depression and comorbidity
Current projects
A randomised controlled trial and cost-effectiveness evaluation of "booster" interventions to sustain increases in physical activity in middle-aged adults in deprived urban neighbourhoods (The Sheffield Physical Activity Booster Study: HTA 07/25/02)
Key publications (since 2008)
- Wyld L, Hind D. Primary endocrine therapy for the treatment of early breast cancer in older women. (in volume edited by Malcolm Reed). In press.
- Carroll C, Ward SE, Hind D. The clinical efficacy of cytotoxic agents in locally advanced or metastatic breast cancer patients pretreated with an anthracycline and a taxane: a systematic review. European Journal of Cancer. In press.
- Hind D, O'Cathain A, Cooper CL, Parry GD, Isaac CL, Rose A, Martin L, Sharrack B. The acceptability of computerised cognitive behavioural therapy for the treatment of depression in people with chronic physical disease: a qualitative study of people with multiple sclerosis. Psychology & Health 2009. 1–14, iFirst.
- Ward S, Pilgrim H, Hind D. Trastuzumab for the treatment of primary breast cancer in HER2-positive women: a single technology appraisal. Health Technology Assessment 2009; Vol. 13: Suppl. 1.
- Al Buhairan B, Hind D, Hutchinson A. Antibiotic prophylaxis for wound infections in total joint arthroplasty: systematic review. J Bone Joint Surg Br 2008; 90-B: 915-919.
- Hind D, Tappenden P, Tumur I, Eggington S, Sutcliffe P, Ryan A. The use of irinotecan, oxaliplatin and raltitrexed for the treatment of advanced colorectal cancer: systematic review and economic evaluation. Health Technol Assess 2008; 12(15):1-182.
Section
I am based in Health Services Research.